tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports

NervGen Pharma (NGEN) Financial Statements

84 Followers

NervGen Pharma Financial Overview

NervGen Pharma's market cap is currently $296.59M. The company's EPS TTM is $-0.2604816; its P/E ratio is -26.17; NervGen Pharma is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Dec 22Dec 21Mar 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -58.23K$ -109.40K$ -84.92K$ -33.70K$ -31.12K
Operating Income$ -17.33M$ -13.41M$ -16.99M$ -10.13M$ -8.79M
EBITDA$ -16.62M$ -16.78M$ -14.82M$ -10.03M$ -8.75M
Net Income$ -16.68M$ -16.89M$ -15.29M$ -10.06M$ -8.78M
Balance Sheet
Cash & Short-Term Investments$ 12.07M$ 8.80M$ 16.56M$ 13.38M$ 4.39M
Total Assets$ 13.54M$ 9.99M$ 17.61M$ 14.15M$ 5.24M
Total Debt$ 73.38K$ 148.78K$ 209.10K$ 0.00$ 0.00
Net Debt$ -11.93M$ -8.65M$ -16.35M$ -13.38M$ -4.39M
Total Liabilities$ 11.75M$ 11.50M$ 7.68M$ 852.33K$ 592.68K
Stockholders' Equity$ 1.79M$ -1.52M$ 9.93M$ 13.30M$ 4.65M
Cash Flow
Free Cash Flow$ -11.70M$ -8.53M$ -13.13M$ -6.54M$ -4.95M
Operating Cash Flow$ -11.70M$ -8.52M$ -13.12M$ -6.54M$ -4.95M
Investing Cash Flow$ 40.91K$ -104.77K$ -15.57K$ -35.64K$ -2.69K
Financing Cash Flow$ 15.77M$ 578.16K$ 16.70M$ 15.51M$ 6.16M
Currency in USD

NervGen Pharma Earnings and Revenue History

Income Statement >

NervGen Pharma Debt to Assets

Balance Sheet >

NervGen Pharma Cash Flow

Cash Flow >

NervGen Pharma Forecast EPS vs Actual EPS

Earnings >